These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1465880

  • 1. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM, Sánchez J, Sánchez P, García J, Orero E, Beneyto I, Ros F.
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract] [Full Text] [Related]

  • 2. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E, Bittar AE, Losekann A, Deboni L, Ceretta F, Goldani JC, Garcia VD.
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
    Schweizer RT, Roper L, Hull D, Bartus SA.
    Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D, Ekberg H, Lindholm A, Persson H, Tufvesson G, Albrechtsen D.
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract] [Full Text] [Related]

  • 5. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM, Sánchez P, Sánchez J, García J, Orero E, Beneyto I, Cruz JM.
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract] [Full Text] [Related]

  • 6. Cyclosporine-related hypercoagulability: fact or fiction?
    Edwards CM, Morgan JD, Donnelly PK.
    Transplant Proc; 1992 Dec; 24(6):2616-7. PubMed ID: 1465885
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
    Park K, Kim YS, Kim SI.
    Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
    [No Abstract] [Full Text] [Related]

  • 8. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
    Arbelaez M, Mejia G, Henao JE, Garcia A, Arango JL, Velasquez A, Restrepo J, Garcia LF.
    Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
    [No Abstract] [Full Text] [Related]

  • 9. Living-unrelated renal transplantation.
    Simforoosh N, Bassiri A, Amiransari B, Gol S.
    Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose OKT3 for cadaveric renal transplantation.
    Schweizer RT, Roper L, Hull D, Bartus SA.
    Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
    [No Abstract] [Full Text] [Related]

  • 11. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation.
    Berthoux FC, Guerin C, Burgard G, Berthoux P, Alamartine E.
    Transplant Proc; 1992 Dec; 24(6):2578-82. PubMed ID: 1465872
    [No Abstract] [Full Text] [Related]

  • 12. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
    Gnant MF, Sautner T, Rosenmayr A, Muehlbacher F.
    Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
    [No Abstract] [Full Text] [Related]

  • 13. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z, Adam K, Parapanissiou E, Sakellariou G, Papakyriazi E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract] [Full Text] [Related]

  • 14. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B, Ekberg H, Johnson U.
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular risk impact of cyclosporine immunosuppression in renal transplant recipients.
    Paul LC, Sutherland F, Klassen J, Buckle S, Burgess E.
    Transplant Proc; 1992 Dec; 24(6):2740-1. PubMed ID: 1465922
    [No Abstract] [Full Text] [Related]

  • 16. Kidney transplantation in Slovenia from 1986 through 1991.
    Kandus A, Buturović-Ponikvar J, Malovrh M, Bren AF.
    Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
    [No Abstract] [Full Text] [Related]

  • 17. Fully parametric analysis of kidney graft survival.
    Vereerstraeten P.
    Transplant Proc; 1992 Dec; 24(6):2411-3. PubMed ID: 1465811
    [No Abstract] [Full Text] [Related]

  • 18. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E, Berthoux F, Acquart S, Lepetit JC.
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract] [Full Text] [Related]

  • 19. DR6 compatibility and kidney graft survival.
    Correia AM, de Costa AG, Reis P, Rego F, Sampaio MJ, Caetano JM, Pena JR.
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract] [Full Text] [Related]

  • 20. Impact of recipient and donor age on the outcome of renal transplantation.
    Rosman J, Steinhäuslin F, David S, Genton A, Mosimann F, Wauters JP.
    Transplant Proc; 1992 Dec; 24(6):2723-4. PubMed ID: 1465916
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.